Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Novel Technologies to Measure Vision-related Quality of Life in Patients With Neurodegenerative Diseases Affecting the Optic Nerve or Retina

NCT07489898 is registered in ClinicalTrials.gov with Nisha Nixon as lead sponsor.

NCT NCT07489898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07489898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Novel Technologies to Measure Vision-related Quality of Life in Patients With Neurodegenerative Diseases Affecting the Optic Nerve or Retina
Lead sponsor
Nisha Nixon
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
March 1, 2030
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

inherited optic neuropathy, neurodegenerative diseases